Evidence map›Paper›PMID 40622636›Full record

ReviewInternational urology and nephrology2026

Comparative efficacy of transperitoneal and retroperitoneal laparoscopic nephroureterectomy for upper tract urothelial carcinoma: a multicenter propensity score-matched study.

Cheng Wang, ShuZhen Ou, Xuan Li, Biao Zhang, Shujun Yang, XinYue Lai, Ziming Kang, WanRong Xu, HengPing Li, JiangHou Wan and 1 more

Abstract readMulticenter StudyComparative StudyReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cheng WangDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.
ShuZhen OuLanzhou University, Lanzhou, Gansu, China.
Xuan LiLanzhou University, Lanzhou, Gansu, China.
Biao ZhangDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.
Shujun YangDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.
XinYue LaiLanzhou University, Lanzhou, Gansu, China.
Ziming KangDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.
WanRong XuDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.
HengPing LiDepartment of Urology, Gansu Provincial Hospital, Lanzhou, Gansu, China.
JiangHou WanDepartment of Urology, Lanzhou University First Hospital, Lanzhou, Gansu, China.
PanFeng ShangDepartment of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China. shangpf@lzu.edu.cn.ORCID http://orcid.org/0009-0000-2493-6004

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpper tract urothelial carcinoma (UTUC) is a relatively rare but clinically significant form of urothelial carcinoma, accounting for 5-10% of all urothelial malignancies. Effective surgical management is crucial for improving patient outcomes. This multicenter propensity score-matched study compares the long-term efficacy and perioperative outcomes of transperitoneal laparoscopic nephroureterectomy (T-LNU) and retroperitoneal laparoscopic nephroureterectomy (R-LNU) in patients with UTUC, with a median follow-up of 52 months.

methodsA retrospective analysis was conducted on data from patients diagnosed with primary UTUC who underwent laparoscopic nephroureterectomy (LNU) across three institutions from January 2014 to June 2022. Propensity score matching (PSM) was performed to adjust for potential selection bias. The primary outcomes included overall survival (OS), cancer-specific survival (CSS), intravesical recurrence-free survival (IVRFS), and metastasis-free survival (MFS). The secondary outcomes included perioperative indicators such as surgical duration, blood loss, and postoperative recovery.

resultsA total of 396 patients were included, with 278 undergoing R-LNU and 118 undergoing T-LNU. After 1:1 propensity score matching, 202 patients (101 in each group) were analyzed. No significant differences were observed in long-term outcomes between the two groups. However, T-LNU was associated with a significantly shorter surgical duration (median 210 min vs. 240 min, p = 0.003), while R-LNU was associated with quicker postoperative gastrointestinal recovery (p = 0.005).

conclusionBoth T-LNU and R-LNU are effective surgical approaches for UTUC, each with distinct advantages. The choice of approach should be tailored to individual patient factors and surgeon expertise. Further studies with larger sample sizes and longer follow-up periods are needed to definitively determine the optimal approach for LNU in patients with UTUC.

Indexed as

Carcinoma, Transitional CellKidney NeoplasmsLaparoscopyNephroureterectomyUreteral NeoplasmsAgedFemaleHumansMaleMiddle AgedPeritoneumPropensity ScoreRetroperitoneal SpaceRetrospective StudiesTreatment OutcomeLaparoscopic nephroureterectomyPropensity score matchingRetroperitonealTransperitonealUpper tract urothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.